CEACAM6 expression and function in tumor biology: a comprehensive review

Area of Science:

• Oncology
• Molecular Biology
• Cell Adhesion

Background:

• Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is an immunoglobulin superfamily protein.
• CEACAM6 is expressed on epithelial and myeloid cells.
• It influences key cancer hallmarks like apoptosis inhibition, drug resistance, and metastasis.

Purpose of the Study:

• To review the multifaceted role of CEACAM6 in diverse cancer types.
• To elucidate CEACAM6's involvement in cancer-related signaling pathways.
• To summarize recent progress in CEACAM6-targeted cancer therapies.

Main Methods:

• Literature review of studies on CEACAM6 in cancer.
• Analysis of CEACAM6 expression patterns and clinical correlations.
• Synthesis of information on CEACAM6 signaling and therapeutic strategies.

Main Results:

• CEACAM6 overexpression is linked to poor prognosis in lung, breast, colorectal, and hepatocellular cancers.
• CEACAM6 facilitates tumor cell invasion, metastasis, and resistance to apoptosis and chemotherapy.
• Differential CEACAM6 expression on tumor cells suggests its utility as a cancer biomarker.

Conclusions:

• CEACAM6 is a significant contributor to cancer progression and a potential biomarker.
• Targeting CEACAM6 presents a promising avenue for novel cancer treatments.
• Further research into CEACAM6's mechanisms and therapeutic applications is warranted.